1. Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC;
2. Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;
3. Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC;
4. Department of Biology, University of North Carolina, Chapel Hill, NC;
5. Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY;
6. Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
7. Department of Biostatistics and Bioinformatics, Duke Cancer Institute, Duke University Medical Center, Durham, NC;
8. Division of Blood and Marrow Transplantation, Department of Pediatrics and
9. Masonic Cancer Center, University of Minnesota, Minneapolis, MN;
10. Department of Discovery Oncology, Genentech, Inc, South San Francisco, CA; and
11. Life Sciences Institute and
12. Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI